Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1984 1
1989 2
1990 1
1996 1
2000 2
2002 1
2008 2
2009 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Advances in vinca-alkaloids: Navelbine.
Marty M, Extra JM, Espie M, Leandri S, Besenval M, Krikorian A. Marty M, et al. Among authors: besenval m. Nouv Rev Fr Hematol. 1989;31(2):77-84. Nouv Rev Fr Hematol. 1989. PMID: 2671933 Review.
Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors.
Gelmon KA, Latreille J, Tolcher A, Génier L, Fisher B, Forand D, D'Aloisio S, Vernillet L, Daigneault L, Lebecq A, Besenval M, Eisenhauer E. Gelmon KA, et al. Among authors: besenval m. J Clin Oncol. 2000 Dec 15;18(24):4098-108. doi: 10.1200/JCO.2000.18.24.4098. J Clin Oncol. 2000. PMID: 11118471 Clinical Trial.
Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer.
Zatloukal P, Gervais R, Vansteenkiste J, Bosquee L, Sessa C, Brain E, Dansin E, Urban T, Dohollou N, Besenval M, Quoix E. Zatloukal P, et al. Among authors: besenval m. J Thorac Oncol. 2008 Aug;3(8):894-901. doi: 10.1097/JTO.0b013e31817e6669. J Thorac Oncol. 2008. PMID: 18670308 Free article. Clinical Trial.
Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors.
Mita AC, Denis LJ, Rowinsky EK, Debono JS, Goetz AD, Ochoa L, Forouzesh B, Beeram M, Patnaik A, Molpus K, Semiond D, Besenval M, Tolcher AW. Mita AC, et al. Among authors: besenval m. Clin Cancer Res. 2009 Jan 15;15(2):723-30. doi: 10.1158/1078-0432.CCR-08-0596. Clin Cancer Res. 2009. PMID: 19147780 Free article. Clinical Trial.
Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors.
Sessa C, Cuvier C, Caldiera S, Bauer J, Van Den Bosch S, Monnerat C, Semiond D, Pérard D, Lebecq A, Besenval M, Marty M. Sessa C, et al. Among authors: besenval m. Ann Oncol. 2002 Jul;13(7):1140-50. doi: 10.1093/annonc/mdf174. Ann Oncol. 2002. PMID: 12176795 Free article. Clinical Trial.
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
Le Chevalier T, Brisgand D, Pujol JL, Douillard JY, Monnier A, Rivière A, Chomy P, Le Groumellec A, Ruffie P, Gottfried M, Gaspard MH, Chevreau C, Alberola V, Cigolari S, Besson F, Martinez A, Besenval M, Berthaud P, Tursz T. Le Chevalier T, et al. Among authors: besenval m. Bull Cancer. 1996 May;83(5):385-94. Bull Cancer. 1996. PMID: 8680091 Clinical Trial. French.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page